CMS extends Appropriate Use Criteria testing period until 2022

The Centers for Medicare & Medicaid Services today announced the extension of its Appropriate Use Criteria testing period through 2021.
This means the AUC program will not impact claims for diagnostic imaging services until Jan. 1, 2022, at the earliest.
The AHA has long advocated for an extension, including most recently in an AHA and American Medical Association joint letter in July. The letter stressed how the COVID-19 public health emergency has resulted in reduced imaging services, adding financial strains and prohibiting providers from sufficiently engaging in the AUC program’s preparatory steps; therefore, AHA is pleased to see CMS implement a delay to this program.
Related News Articles
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…